Wells Pharma of Houston LLC recalls fentaNYL Citrate Injectable Solution
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- cGMP deviations.
- Products
-
- fentaNYL Citrate Injectable Solution
- Company
- Wells Pharma of Houston LLC
- Where it was sold
-
U.S. Nationwide.
Nationwide
- Units affected
- 4,030 IV Bags
- About this recall
- fentaNYL Citrate Injectable Solution, NARCOTIC, Cii, 1000 mcg/100 mL (10 mcg per mL), 100 mL bag, Wells Pharma in Houston, NDC 73702-202-02.